vs
Side-by-side financial comparison of SMITH & WESSON BRANDS, INC. (SWBI) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.
SMITH & WESSON BRANDS, INC. is the larger business by last-quarter revenue ($124.7M vs $76.2M, roughly 1.6× VIEMED HEALTHCARE, INC.). VIEMED HEALTHCARE, INC. runs the higher net margin — 7.4% vs 1.5%, a 5.9% gap on every dollar of revenue. On growth, VIEMED HEALTHCARE, INC. posted the faster year-over-year revenue change (25.5% vs -3.9%). SMITH & WESSON BRANDS, INC. produced more free cash flow last quarter ($16.3M vs $9.7M). Over the past eight quarters, VIEMED HEALTHCARE, INC.'s revenue compounded faster (22.7% CAGR vs -4.8%).
Smith & Wesson Brands, Inc. (S&W) is an American firearm manufacturer headquartered in Maryville, Tennessee, United States.
Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.
SWBI vs VMD — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $124.7M | $76.2M |
| Net Profit | $1.9M | $5.6M |
| Gross Margin | 24.3% | 57.9% |
| Operating Margin | 3.3% | 11.0% |
| Net Margin | 1.5% | 7.4% |
| Revenue YoY | -3.9% | 25.5% |
| Net Profit YoY | -53.6% | 30.7% |
| EPS (diluted) | $0.04 | $0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $124.7M | $76.2M | ||
| Q3 25 | $85.1M | $71.9M | ||
| Q2 25 | $140.8M | $63.1M | ||
| Q1 25 | $115.9M | $59.1M | ||
| Q4 24 | $129.7M | $60.7M | ||
| Q3 24 | $88.3M | $58.0M | ||
| Q2 24 | $159.1M | $55.0M | ||
| Q1 24 | $137.5M | $50.6M |
| Q4 25 | $1.9M | $5.6M | ||
| Q3 25 | $-3.4M | $3.5M | ||
| Q2 25 | $8.6M | $3.2M | ||
| Q1 25 | $2.1M | $2.6M | ||
| Q4 24 | $4.5M | $4.3M | ||
| Q3 24 | $-1.9M | $3.9M | ||
| Q2 24 | $27.9M | $1.5M | ||
| Q1 24 | $7.9M | $1.6M |
| Q4 25 | 24.3% | 57.9% | ||
| Q3 25 | 25.9% | 57.5% | ||
| Q2 25 | 28.8% | 58.3% | ||
| Q1 25 | 24.1% | 56.3% | ||
| Q4 24 | 26.6% | 59.5% | ||
| Q3 24 | 27.4% | 59.3% | ||
| Q2 24 | 35.5% | 59.8% | ||
| Q1 24 | 28.7% | 58.9% |
| Q4 25 | 3.3% | 11.0% | ||
| Q3 25 | -3.5% | 7.8% | ||
| Q2 25 | 9.3% | 8.1% | ||
| Q1 25 | 4.1% | 6.5% | ||
| Q4 24 | 5.8% | 10.6% | ||
| Q3 24 | -1.7% | 9.7% | ||
| Q2 24 | 17.4% | 6.6% | ||
| Q1 24 | 8.2% | 4.4% |
| Q4 25 | 1.5% | 7.4% | ||
| Q3 25 | -4.0% | 4.9% | ||
| Q2 25 | 6.1% | 5.0% | ||
| Q1 25 | 1.8% | 4.4% | ||
| Q4 24 | 3.5% | 7.1% | ||
| Q3 24 | -2.1% | 6.7% | ||
| Q2 24 | 17.5% | 2.7% | ||
| Q1 24 | 5.7% | 3.2% |
| Q4 25 | $0.04 | $0.14 | ||
| Q3 25 | $-0.08 | $0.09 | ||
| Q2 25 | $0.19 | $0.08 | ||
| Q1 25 | $0.05 | $0.06 | ||
| Q4 24 | $0.10 | $0.10 | ||
| Q3 24 | $-0.04 | $0.10 | ||
| Q2 24 | $0.60 | $0.04 | ||
| Q1 24 | $0.17 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $22.4M | $13.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $363.2M | $141.5M |
| Total Assets | $548.6M | $199.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $22.4M | $13.5M | ||
| Q3 25 | $18.0M | $11.1M | ||
| Q2 25 | $25.2M | $20.0M | ||
| Q1 25 | $26.7M | $10.2M | ||
| Q4 24 | $39.1M | $17.5M | ||
| Q3 24 | $35.5M | $11.3M | ||
| Q2 24 | $60.8M | $8.8M | ||
| Q1 24 | $47.4M | $7.3M |
| Q4 25 | $363.2M | $141.5M | ||
| Q3 25 | $364.4M | $133.6M | ||
| Q2 25 | $372.5M | $139.7M | ||
| Q1 25 | $366.9M | $134.8M | ||
| Q4 24 | $371.5M | $131.4M | ||
| Q3 24 | $380.0M | $125.0M | ||
| Q2 24 | $399.9M | $119.4M | ||
| Q1 24 | $376.4M | $116.3M |
| Q4 25 | $548.6M | $199.2M | ||
| Q3 25 | $554.6M | $202.4M | ||
| Q2 25 | $559.6M | $184.6M | ||
| Q1 25 | $578.9M | $178.1M | ||
| Q4 24 | $587.4M | $177.1M | ||
| Q3 24 | $571.3M | $169.5M | ||
| Q2 24 | $577.4M | $163.9M | ||
| Q1 24 | $570.6M | $154.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $27.3M | $18.4M |
| Free Cash FlowOCF − Capex | $16.3M | $9.7M |
| FCF MarginFCF / Revenue | 13.1% | 12.7% |
| Capex IntensityCapex / Revenue | 8.8% | 11.5% |
| Cash ConversionOCF / Net Profit | 14.22× | 3.27× |
| TTM Free Cash FlowTrailing 4 quarters | $21.3M | $11.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $27.3M | $18.4M | ||
| Q3 25 | $-8.1M | $18.4M | ||
| Q2 25 | $40.8M | $12.3M | ||
| Q1 25 | $-9.8M | $2.9M | ||
| Q4 24 | $-7.4M | $15.0M | ||
| Q3 24 | $-30.8M | $12.7M | ||
| Q2 24 | $43.7M | $10.2M | ||
| Q1 24 | $25.2M | $1.2M |
| Q4 25 | $16.3M | $9.7M | ||
| Q3 25 | $-12.4M | $10.7M | ||
| Q2 25 | $33.5M | $4.1M | ||
| Q1 25 | $-16.1M | $-12.6M | ||
| Q4 24 | $-10.7M | $3.2M | ||
| Q3 24 | $-35.5M | $1.7M | ||
| Q2 24 | $38.2M | $1.2M | ||
| Q1 24 | $7.0M | $-4.8M |
| Q4 25 | 13.1% | 12.7% | ||
| Q3 25 | -14.6% | 14.9% | ||
| Q2 25 | 23.8% | 6.5% | ||
| Q1 25 | -13.9% | -21.4% | ||
| Q4 24 | -8.3% | 5.2% | ||
| Q3 24 | -40.2% | 3.0% | ||
| Q2 24 | 24.0% | 2.3% | ||
| Q1 24 | 5.1% | -9.5% |
| Q4 25 | 8.8% | 11.5% | ||
| Q3 25 | 5.0% | 10.6% | ||
| Q2 25 | 5.2% | 12.9% | ||
| Q1 25 | 5.4% | 26.2% | ||
| Q4 24 | 2.5% | 19.5% | ||
| Q3 24 | 5.3% | 19.0% | ||
| Q2 24 | 3.5% | 16.3% | ||
| Q1 24 | 13.2% | 11.9% |
| Q4 25 | 14.22× | 3.27× | ||
| Q3 25 | — | 5.23× | ||
| Q2 25 | 4.73× | 3.88× | ||
| Q1 25 | -4.68× | 1.09× | ||
| Q4 24 | -1.63× | 3.47× | ||
| Q3 24 | — | 3.29× | ||
| Q2 24 | 1.57× | 6.94× | ||
| Q1 24 | 3.20× | 0.73× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
